Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Azabicyclane citrate
RN: 21650-02-2
UNII: ZL0S1960NF
InChIKey: UZKDXESOJFBSJS-JXMYBXCISA-N

Classification Codes

  • Drug / Therapeutic Agent
  • Reproductive Effect

Molecular Formula

  • C16-H23-N-O.C6-H8-O7

Molecular Weight

  • 437.486
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Results Name

  • Azabicyclane citrate

Name of Substance

  • Azabicyclane

Synonyms

  • 4-beta-Methoxy-1-methyl-4-alpha-phenyl-3-alpha,5-alpha-propanopiperidine hydrogen citrate
  • 9-beta-Methoxy-9-alpha-phenyl-3-methyl-3-azabicyclo(3.3.1)nonane citrate
  • 9-Methoxy-3-methyl-9-phenyl-3-azabicyclo(3.3.1)nonane syn-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
  • Azabicyclane citrate
  • UNII-ZL0S1960NF

Systematic Names

  • 3-Azabicyclo(3.3.1)nonane, 9-methoxy-3-methyl-9-phenyl-, citrate (1:1), stereoisomer
  • 3-Azabicyclo(3.3.1)nonane, 9-methoxy-3-methyl-9-phenyl-, syn-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

Registry Numbers

CAS Registry Number

  • 21650-02-2

FDA UNII

  • ZL0S1960NF

System Generated Number

  • 0021650022

Molecular Formulas

Molecular Formula

  • C16-H23-N-O.C6-H8-O7

Molecular Formula Fragments

  • C16-H23-N-O
  • C6-H8-O7
  • COMPONENT

Structure Descriptors

InChI

1S/C16H23NO.C6H8O7/c1-17-11-14-9-6-10-15(12-17)16(14,18-2)13-7-4-3-5-8-13;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-5,7-8,14-15H,6,9-12H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t14-,15+,16?;

InChIKey

UZKDXESOJFBSJS-JXMYBXCISA-N

Smiles

C(C(C(O)=O)(O)CC(=O)O)C(=O)O.c1ccc(cc1)C1([C@@H]2CCC[C@H]1CN(C2)C)OC

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 56mg/kg (56mg/kg) BEHAVIORAL: ANALGESIA

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
Toxicology and Applied Pharmacology. Vol. 17, Pg. 344, 1970.
mouse LD50 oral 300mg/kg (300mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

BEHAVIORAL: ANALGESIA
Toxicology and Applied Pharmacology. Vol. 17, Pg. 344, 1970.
mouse LD50 subcutaneous 200mg/kg (200mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: ANALGESIA

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
Toxicology and Applied Pharmacology. Vol. 17, Pg. 344, 1970.
rat LD50 intraperitoneal 93800ug/kg (93.8mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 3, Pg. 195, 1972.
rat LD50 intravenous 74100ug/kg (74.1mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 3, Pg. 195, 1972.
rat LD50 subcutaneous 130mg/kg (130mg/kg) VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

BEHAVIORAL: ANALGESIA

SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
Toxicology and Applied Pharmacology. Vol. 17, Pg. 344, 1970.